Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

Company Overview

Universe Pharmaceuticals Inc. (NASDAQ: UPC) is a China-based pharmaceutical and healthcare products company. The company develops, manufactures and markets pharmaceutical products, health supplements and medical devices, with an emphasis on traditional Chinese medicine and other products used in everyday healthcare.

Its product portfolio includes over-the-counter and prescription medicines designed to address a range of conditions, including respiratory, cardiovascular, digestive and dermatological ailments. Universe Pharmaceuticals also offers healthcare products and related medical devices through its distribution and sales channels.

The company is headquartered in Xi’an, Shaanxi Province, China, and primarily serves the Chinese market. Universe Pharmaceuticals has operated in the pharmaceutical and healthcare sector since the late 1990s and has expanded its business through manufacturing, product development and commercial distribution activities.

Key Stats

• Today's Range: $4.61 to $4.99
• 50-Day Range: $3.16 to $7.09
• 52-Week Range: $2.00 to $17.96
• Volume: 28,201 shs
• Average Volume: 330,988 shs
• Market Capitalization: $24.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Universe Pharmaceuticals Stock Analysis - MarketRank™

Universe Pharmaceuticals scored higher than 10% of companies evaluated by MarketBeat, and ranked 868th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Universe Pharmaceuticals has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Universe Pharmaceuticals has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Universe Pharmaceuticals has a P/B Ratio of 0.05. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.54% of the float of Universe Pharmaceuticals has been sold short.

Short Interest Ratio / Days to Cover

Universe Pharmaceuticals has a short interest ratio ("days to cover") of 0.13, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Universe Pharmaceuticals has recently increased by 154.75%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Universe Pharmaceuticals does not currently pay a dividend.

Dividend Growth

Universe Pharmaceuticals does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.26

News Sentiment

Universe Pharmaceuticals has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Universe Pharmaceuticals this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for UPC on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Universe Pharmaceuticals insiders have not sold or bought any company stock.

Percentage Held by Insiders

57.38% of the stock of Universe Pharmaceuticals is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.18% of the stock of Universe Pharmaceuticals is held by institutions.

Company Calendar

• Last Earnings: 7/29/2026
• Today: 9/28/2026
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:UPC
• Previous Symbol: NYSE:UPC
• CIK: 1809616
• Web: www.universe-pharmacy.com
• Phone: 86-0796-8403309
• Fax: N/A
• Employees: 216
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.04
• Current Ratio: 4.05
• Quick Ratio: 3.90

Sales & Book Value

• Annual Sales: $17.86 million
• Price / Sales: 1.35
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $99.64 per share
• Price / Book: 0.05

Miscellaneous

• Outstanding Shares: 5,020,000
• Free Float: 2,141,000
• Market Cap: $24.10 million
• Optionable: N/A
• Beta: 1.58